.png){kind=icon}
返回
Neuroblastoma, Version 2.2024
.png){kind=icon}
OA
AI
DOI：10.6004/jnccn.2024.7013.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Neuroblastoma is the most common extracranial solid tumor diagnosed in children. This inaugural version of the NCCN Guidelines for Neuroblastoma provides recommendations for the diagnosis, risk classification, and treatment of neuroblastoma. The information in these guidelines was developed by the NCCN Neuroblastoma Panel, a multidisciplinary group of representatives with expertise in neuroblastoma, consisting of pediatric oncologists, radiologists, pathologists, surgeons, and radiation oncologists from NCCN Member Institutions. The evidence-based and consensus recommendations contained in the NCCN Guidelines are intended to guide clinicians in selecting the most appropriate treatments for their patients with this clinically heterogeneous disease.
Keyword:
HIGH-RISK NEUROBLASTOMA
CHILDRENS-ONCOLOGY-GROUP
PATHOLOGY CLASSIFICATION
MYOCLONUS SYNDROME
PROGNOSTIC IMPACT
N-MYC
CHEMOTHERAPY
MUTATIONS
CRITERIA
SURVIVAL
期刊
J
IF:
16.4
论文数:
2.8K
被引数:
1.5W
机构
查看更多机构
.png){kind=icon}
